Today: 10 June 2026
Browse Category

NASDAQ:CAI 30 December 2025 - 12 January 2026

Caris Life Sciences (CAI) stock drops on preliminary 2025 results, Everlywell cancer-screening deal

Caris Life Sciences (CAI) stock drops on preliminary 2025 results, Everlywell cancer-screening deal

Caris Life Sciences shares fell 8.5% to $26.08 in afternoon trading after the company reported preliminary 2025 revenue near $800 million, up 94%, but warned of significant prior-period adjustments. The company also announced a partnership with Everlywell to develop a blood-based early cancer detection test, with more details expected at the JPMorgan Healthcare Conference later Monday.
12 January 2026
··
Why Caris Life Sciences (CAI) stock is down today as biotech slips

Why Caris Life Sciences (CAI) stock is down today as biotech slips

Caris Life Sciences shares fell 1.8% to $27.44 by 2:41 p.m. ET Tuesday, underperforming biotech peers as sector benchmarks declined. The drop followed recent attention on Caris’ Genentech partnership, which includes $25 million upfront and up to $1.1 billion in potential milestones. The S&P 500 and Nasdaq were flat. Investors are watching Caris’ test volumes and revenue guidance.
30 December 2025

Stock Market Today

  • Tazmo Co., Ltd. (TSE:6266) Shows Strong Growth Potential Amid Undervaluation
    June 9, 2026, 6:34 PM EDT. Tazmo Co., Ltd. (TSE:6266) leads Tokyo Stock Exchange gainers with recent price hikes but remains below yearly highs. The semiconductor company's price-to-earnings (PE) ratio stands at 18.43x, significantly under the industry average of 24.17x, suggesting undervaluation. Its high beta indicates notable stock price volatility, presenting buying opportunities. Analysts forecast a robust profit growth of 64% over the next two years, implying a positive outlook not fully priced in yet. Investors may consider accumulating shares, though factors like capital structure warrant attention. Potential buyers might find the current valuation attractive amid expected earnings expansion, but should assess all risks before entering.

Latest articles

Xcel Brands Pops on Coco Rocha-Baggallini News; Small Float Triggers Move

Xcel Brands Pops on Coco Rocha-Baggallini News; Small Float Triggers Move

10 June 2026
Xcel Brands soared 10.5% to $2.10 on record volume after announcing an exclusive Baggallini-Coco Rocha handbag deal, despite reporting a $2.5 million Q1 net loss and just $0.2 million in cash; with under 4 million shares in its float and potential for future stock dilution, investors face both sharp price swings and ongoing financial risks.
D-Wave Quantum Drops Almost 9% As QBTS Grabs Attention Again

D-Wave Quantum Drops Almost 9% As QBTS Grabs Attention Again

10 June 2026
D-Wave Quantum plunged 8.94% to $23.52 as investors dumped speculative tech stocks ahead of key inflation data, despite the company touting a 1,994% surge in Q1 bookings and a potential $100 million federal award that is not yet finalized; revenue fell 81% and D-Wave posted an $18.4 million net loss, with rivals IonQ, Rigetti, and Quantum Computing Inc. also down about 9–10%.
Ford AI, energy gains pause after rally

Ford AI, energy gains pause after rally

10 June 2026
Ford shares dipped to $14.95 in late trading as investors weighed GM’s new sodium-ion battery partnership against Ford’s own $17 billion energy-storage rally, with May sales down 13.6% and EDF deliveries not expected until 2028, leaving the stock’s future tied to contracting momentum and regulatory advantages.
NuScale Tumbles as Nuclear-AI Trade Hits Bump

NuScale Tumbles as Nuclear-AI Trade Hits Bump

10 June 2026
NuScale Power plunged 7.2% to $10.00 on heavy volume as investors cut exposure to speculative nuclear stocks amid a Nasdaq selloff, with no new contracts announced and revenue down sharply year-over-year; the company’s future hinges on landing binding module deals and project financing, leaving shares sensitive to risk-off sentiment.
Visa, Mastercard get court win in $38 billion swipe-fee case

Visa, Mastercard get court win in $38 billion swipe-fee case

10 June 2026
Visa and Mastercard shares jumped 1.7% and 2% after a Brooklyn judge gave preliminary approval to their $38 billion swipe-fee settlement with U.S. merchants, a deal expected to save merchants $38 billion by 2031 and cap standard consumer-card rates at 1.25% for eight years, though major retailers and trade groups remain opposed.
Go toTop